Werewolf Therapeutics, Inc. — All Filings
368 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0000950170-24-001956 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | 4 | 0000950170-24-001932 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | 4 | 0000950170-24-001915 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | 4 | 0000950170-24-001907 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | 4 | 0000950170-24-001894 | Jan 4, 2024 | Jan 2, 2024 |
| SC 13G | WEREWOLF THERAPEUTICS, INC. | 0000902664-23-005971 | Dec 21, 2023 | — |
| 8-K | 8-K | 0001785530-23-000034 | Nov 14, 2023 | — |
| 10-Q | 10-Q | 0001785530-23-000033 | Nov 14, 2023 | Sep 30, 2023 |
| 8-K | 8-K | 0001193125-23-269869 | Nov 3, 2023 | — |
| 8-K | 8-K | 0001193125-23-236531 | Sep 18, 2023 | — |
| 8-K | 8-K | 0001785530-23-000027 | Aug 10, 2023 | — |
| 10-Q | 10-Q | 0001785530-23-000025 | Aug 10, 2023 | Jun 30, 2023 |
| 8-K | 8-K | 0001193125-23-176190 | Jun 27, 2023 | Jun 21, 2023 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-23-074338 | Jun 23, 2023 | Jun 21, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-016389 | Jun 23, 2023 | Jun 21, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-016382 | Jun 23, 2023 | Jun 21, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-016380 | Jun 23, 2023 | Jun 21, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-016379 | Jun 23, 2023 | Jun 21, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-016376 | Jun 23, 2023 | Jun 21, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-016373 | Jun 23, 2023 | Jun 21, 2023 |
| 10-Q | 10-Q | 0001785530-23-000017 | May 11, 2023 | Mar 31, 2023 |
| 8-K | 8-K | 0001785530-23-000016 | May 11, 2023 | — |
| ARS | ARS | 0001193125-23-127522 | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | DEFA14A | 0001140361-23-020742 | Apr 27, 2023 | — |
| DEF 14A | DEF 14A | 0001140361-23-020741 | Apr 27, 2023 | Jun 21, 2023 |
| S-8 | S-8 | 0001785530-23-000010 | Mar 23, 2023 | — |
| 10-K | 10-K | 0001785530-23-000009 | Mar 23, 2023 | Dec 31, 2022 |
| 8-K | 8-K | 0001785530-23-000007 | Mar 23, 2023 | — |
| 8-K | 8-K | 0001193125-23-076684 | Mar 22, 2023 | Mar 16, 2023 |
| SC 13G | SC 13G | 0001104659-23-018466 | Feb 10, 2023 | — |
| SC 13G | SC 13G | 0001104659-23-004233 | Jan 17, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-004169 | Jan 17, 2023 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-23-002799 | Jan 10, 2023 | Jan 6, 2023 |
| SC 13D/A | SC 13D/A | 0001104659-23-002796 | Jan 10, 2023 | — |
| 8-K | 8-K | 0001193125-23-005618 | Jan 10, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-23-001413 | Jan 9, 2023 | Jan 3, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-001410 | Jan 9, 2023 | Jan 3, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-001409 | Jan 9, 2023 | Jan 3, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-001408 | Jan 9, 2023 | Jan 3, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-001407 | Jan 9, 2023 | Jan 3, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-001404 | Jan 9, 2023 | Jan 3, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-001400 | Jan 9, 2023 | Jan 3, 2023 |
| 10-Q | 10-Q | 0001785530-22-000038 | Nov 10, 2022 | Sep 30, 2022 |
| 8-K | 8-K | 0001785530-22-000037 | Nov 10, 2022 | — |
| 8-K | 8-K | 0001193125-22-239984 | Sep 7, 2022 | Aug 31, 2022 |
| SC 13D/A | SC 13D/A | 0001104659-22-090110 | Aug 12, 2022 | — |
| 10-Q | 10-Q | 0001785530-22-000031 | Aug 11, 2022 | Jun 30, 2022 |
| 8-K | 8-K | 0001785530-22-000030 | Aug 11, 2022 | — |
| 8-K | 8-K | 0001193125-22-169285 | Jun 7, 2022 | Jun 1, 2022 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-22-068178 | Jun 3, 2022 | Jun 1, 2022 |